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OBJECTIVE: To evaluate intraoperative hypothermia as a
predictor for morbidity after open abdominal surgery for
ovarian cancer.
METHODS: This cohort study included 146 women with
stage IIIC and IV ovarian cancer who underwent debulk-
ing surgery at our institution from January 1, 2001,
through December 31, 2003. Hypothermia was defined as
end operative temperature lower than 36°C. Early com-
plications (occurring within 30 days of surgery) included:
mortality, infectious morbidities, cardiovascular events,
venous thromboembolic (VTE) events, anastomotic leak,
readmission, and reoperation. Survival was also evalu-
ated. Logistic regression models were used to adjust for
known confounders.
RESULTS: The mean age was 63.911.7 years; 46 (32%)
patients had a body mass index higher than 30; mean
operative time was 23985 minutes. There were five
deaths perioperatively, all in the hypothermic group.
Hypothermia was associated with an increased risk of any
early complications (34 [42.0%] compared with 11
[16.9%]) with an adjusted odds ratio (OR) of 3.40 (95%
confidence interval [CI] 1.48–8.33). For individual com-
plications, hypothermic patients were at higher risk for
VTE events with an adjusted OR of 3.53 (95% CI 1.02–
16.44); infectious morbidity with an adjusted OR of 2.99
(95% CI 0.97–11.35); and reoperation with an adjusted
OR of 4.96 (95% CI 0.80–95.7). The overall survival was
shorter in hypothermic group with a median of 34
compared with 45 months (P.045); this remained signif-
icant for an optimally resected subgroup with a median
overall survival of 40 compared with 48 months (P.049).
CONCLUSION: Surgical hypothermia is an independent
predictor of early perioperative complications and over-
all survival after cytoreductive surgery for ovarian cancer.
This is a critically important finding, because maintaining
normothermia is an inexpensive modifiable factor, which
could result in reduced morbidity.
LEVEL OF EVIDENCE: II
(Obstet Gynecol 2012;119:590–6)
DOI: 10.1097/AOG.0b013e3182475f8a
Perioperative hypothermia is common in patientsundergoing major open abdominal surgery. Vis-
ceral and peritoneal surface exposure to room tem-
perature and anesthetic-induced impairment of ther-
moregulatory control are the most accepted etiologies
of intraoperative hypothermia.1 Patients undergoing
cytoreductive surgery for ovarian cancer are at high
risk of intraoperative hypothermia as a result of the
previously mentioned factors combined with long
operative times with long incisions and large intrave-
nous fluid requirements. Ascites production, its re-
moval, and evaporation during surgery may also
contribute to lowering body temperature. Most pub-
lished literature defines operative hypothermia as a
core body temperature of less than 36°C.2–4 Studies
have shown that hypothermia is associated with in-
creased perioperative blood loss and higher blood
transfusion rates; it is also associated with increased
rates of surgical wound infection, prolonged hospital-
ization, and increased incidence of postoperative ad-
verse myocardial events.2–4
The overall rate of complications after cytoreduc-
tion for ovarian cancer is at least 20% dependent on
risk factors and surgical complexity.5 Among the
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potential predisposing factors for postoperative com-
plications, hypothermia is one that can be prevented
or minimized with active warming measures during
surgery. To examine the possible effect of intraoper-
ative hypothermia in patients with advanced ovarian
cancer undergoing cytoreductive surgery, we per-
formed a retrospective study and tested the hypothe-
sis that intraoperative hypothermia is associated with
a greater incidence of perioperative complications.
MATERIALS AND METHODS
The Mayo Clinic institutional review board reviewed
and approved this cohort study. The article was
written in accordance with the Strengthening the
Reporting of Observational Studies in Epidemiology
statement.6 Only those patients who approved the use
of their medical records for research were included in
the study.
The cohort of patients diagnosed with primary
epithelial ovarian cancer between January 1, 2001,
and December 31, 2003, was identified from surgical
records using the electronic medical records linkage
system at Mayo Clinic. Only patients undergoing
primary surgical exploration with a postoperative
diagnosis of stage IIIC or IV epithelial ovarian cancer
were included. To obtain a homogeneous population
undergoing similar cytoreductive surgeries for com-
parisons, patients with disease limited to the pelvis
with retroperitoneal involvement only (upstaged to
IIIC disease solely by virtue of lymph nodal involve-
ment) were excluded from the analysis because they
require less extensive operations and have a signifi-
cantly better prognosis.5 Preoperative medical evalu-
ations were performed for all patients, and each was
classified by American Society of Anesthesiologists
score. All patients were scheduled for treatment with
intravenous first-line postoperative platinum-based
chemotherapy.
All patients underwent exploratory laparotomy
with attempted maximal cytoreduction. All patients
underwent active warming during surgery, predomi-
nantly with an upper body forced-air warmer. Fluid
warmers were used at the discretion of the anesthesi-
ologists, and all patients received perioperative anti-
biotics. All surgeries were performed by experienced
gynecologic oncologists at Mayo Clinic using similar
teams, perioperative care, and a standardized surgical
strategy. Perioperative variables such as end operative
temperature, age, body mass index (BMI, calculated
as weight (kg)/[height (m)]2), American Society of
Anesthesiologists score, length of operation, per-
formed procedures, and size of largest residual disease
were recorded and extracted for data analysis. The
complexity of the procedure was quantified using the
surgical complexity score previously developed and
validated.7 Scores ranging from 1 to 3 were assigned
for specific surgical procedures based on the com-
plexity of the procedure and a nominal scale stratifies
cases into low, intermediate, or high complexity
groups.
Hypothermia was defined as a core body temper-
ature lower than 36°C at the time of closure of the
abdominal incision. Temperature was monitored
through an esophageal probe during all procedures.
Early postoperative morbidity was the primary out-
come in this study and was defined as the occurrence
of a listed complication occurring within 30 days of
surgery. These complications included mortality; in-
fectious complications including wound infection,
pneumonia, or other documented infections within
the perioperative period; venous thromboembolic
(VTE) events including deep venous thrombosis and
pulmonary embolism; cardiac events such as myocar-
dial infarction or arrhythmias requiring treatment;
bleeding diathesis; and anastomotic leak. Blood trans-
fusion during the perioperative period was also re-
corded. Secondary outcomes included 5-year overall
survival and disease-free survival. Survival data were
ascertained from follow-up data extracted from elec-
tronic medical records at the Mayo Clinic, the Mayo
Clinic Cancer Center Registry Database, and corre-
spondence from referral institutions.
Continuous data with normal distribution are
presented as mean (standard deviation); median and
range are used for skewed data. Categorical data are
presented as number and percent of patients. Baseline
characteristics of treatment cohorts were compared
using the t test or Wilcoxon rank sum (Mann-Whit-
ney) test for continuous variables according to the
distribution, and 2 test or Fisher exact test were used
for comparison of categorical variables as appropri-
ate. For statistical purposes, variables were stratified
in the following manner into two groups which in-
cluded age (75 years or older compared with younger
than 75 years); American Society of Anesthesiologists
status (American Society of Anesthesiologists 1 or 2
compared with American Society of Anesthesiologists
3 or 4); operative time (4 hours or less compared with
more than 4 hours); BMI (obese [BMI higher than 30]
compared with nonobese); and residual disease (1 cm
or less compared with more than 1 cm). Complexity
of surgery was used in the analyses as a nominal
variable (low, intermediate, or high surgical complex-
ity). A collective end point including all postoperative
complications was the primary end point of the study.
Logistic regression models were used to adjust for
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known confounders including age, BMI, preoperative
albumin level, length of operation, surgical complex-
ity, and the American Society of Anesthesiologists
score. Kaplan-Meier survival curves were used to
compare the time to event (death or recurrence)
between a patient with hypothermia and a patient
with no hypothermia. Differences were considered
statistically significant at P.05. All statistical analyses
were performed using JMP 8.0.
RESULTS
One hundred forty-six patients met criteria for inclu-
sion. The mean age was 63.911.7 years; 46 (31.5%)
patient had a BMI higher than 30; 99 (68%) were
stage IIIC and 47 (32%) were stage IV; 84 (57%) were
classified as American Society of Anesthesiologists
score of 3 or 4; and mean operative time was 23985
minutes. Bowel resection was performed in 29 (19%)
of cases, and overall 81% of the patients had high or
intermediate surgical complexity score, which is con-
sistent with an aggressive surgical approach in ad-
vanced stage disease. Eighty-one patients (55%) had
end operative temperature of less than 36°C. The
mean end operative temperature in the hyperthermia
group was 36.50.38°C with a median of 36.5°C
(range, 36–37.5°C) compared with 35.20.63°C with
a median of 35.3°C (range 33.4–35.9°C) in the hypo-
thermic group. Variables for normothermic and hy-
pothermic cases are shown in Table 1 and groups
were comparable except for a higher percentage of
cases older than 75 years old in the hypothermic
group.
Early postoperative complications occurred in 45
(30.8%) of the included patients. Early complications
of any type occurred in 34 (42.0%) of patients in the
hypothermic group compared with 11 (16.9%) of
normothermic patients with an unadjusted OR of 3.55
(95% confidence interval [CI] 1.66–8.07) and an
adjusted OR of 3.4 (95% CI 1.48–8.33). Hypother-
mia, age, and American Society of Anesthesiologists
score were all independently associated with early
complications, whereas other potential confounding
factors such as BMI, length of operation, and surgical
complexity did not appear to be associated with
postoperative complications. Preoperative albumin
was recorded in 50 of 146 (34.2%) with a mean of
3.40.7 g/dL with a median of 3.4 g/dL (range
2.0–4.4) with no difference in percent of patients with
albumin less than 3 g/dL between the patients who
had end operative temperatures lower than 36°C and
higher than 36°C. After adjustment for albumin level,
end operative temperature less than 36°C remained
significantly associated with early complications when
both variables were included in multivariate model
with an adjusted OR for end operative temperature
less than 36°C of 6.2 (95% CI 1.3–45.2, P.024).
Serum albumin was not available for the majority of
the patients so we were unable to include it in the
adjusted models (Table 2).
There were five (3.4%) deaths within the first 30
postoperative days. All of these cases had end oper-
ative temperature of less than 36°C. Infectious mor-
bidity was significantly increased in hypothermic
patients with an unadjusted OR of 3.19 (95% CI
1.08–11.71); however, after adjustment, this was not
significant with an adjusted OR of 2.99 (95% CI
0.97–11.35). Hypothermic patients had a higher like-
lihood of VTE events with an unadjusted OR of 4.32
(95% CI 1.33–19.37) and adjusted OR of 3.53 (95%
CI 1.02–16.44). Hypothermic patients were more
likely to received more than 2 units of blood transfu-
sion with an unadjusted OR of 4.09 (95% CI 2.07–
8.31) and an adjusted OR of 4.79 (95% CI 2.22–
10.81). For many rare individual complications, there
was no significant increased risk in the hypothermia
cases. The actual rates of anastomotic leak (2.7%
Table 1. Demographic and Baseline
Characteristics of the Study Population
Variable
Hypothermic
(n81)
Normothermic
(n65) P
Age 75 y or older 21 (25.9) 8 (12.3) .040
Body mass index
higher than 30
kg/m2
21 (25.9) 25 (38.5) .105
ASA score of 3 or 4 49 (60.5) 35 (53.8) .419
Operative time longer
than 4 h
36 (44.4) 24 (36.9) .359
Surgical stage
IV 29 (35.8) 18 (27.7) .297
IIIC 52 (64.2) 47 (72.3)
Cytoreduction to no
visible
residual
disease
19 (23.5) 20 (30.8) .321
Cytoreduction to
residual
disease 1 cm
or less
59 (72.8) 48 (73.8) .891
Albumin 3 g/dL* or
less
12/27 (44.4) 6/23 (26.1) .178
Surgical complexity
score
Low 14 (17.3) 14 (21.5)
Intermediate 51 (63) 35 (53.8) .538
High 16 (19.8) 16 (24.6)
ASA, American Society of Anesthesiologists.
Data are n (%) or n/N (%) unless otherwise specified.
* Albumin level not available for all patients.
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compared with 0.7%), cardiovascular events (4.1%
compared with 0.7%), readmission (3.4% compared
with 0.7%), and reoperation (4.8% compared with
0.7%) were all higher in the hypothermia group
compared with the normothermia group (Table 3). Of
those rare complications, only reoperation was signif-
icantly correlated to hypothermia after adjustment for
other known confounders with an adjusted OR of
4.96 (95% CI 0.80–95.7).
Finally, we observed a decreased 5-year overall
survival in the hypothermic patient with a median
overall survival of 34 months compared with 45
month (P.045) when considering all patients (Fig. 1).
In the optimally resected to less than 1-cm subgroup
of cases, the difference in overall survival remained
significant with a median overall survival of 40
months compared with 48 months (P.049) (Fig. 2A).
This survival difference was not observed in the
subgroup of patients in whom optimal debulking of
less than 1 cm was not achieved (Fig. 2B).
DISCUSSION
Although hypothermia has been studied in other
surgical disciplines, its role in gynecologic surgery has
not been previously described. The present study
shows that intraoperative hypothermia is a significant
and independent risk factor for early postoperative
complications and early mortality in women under-
going ovarian cancer cytoreductive surgery. Women
with intraoperative hypothermia are three times more
likely to experience a postoperative complication
compared with women who maintained normal
temperature during the operation. Hypothermic
patients also appear to be significantly more likely
to experience VTE events and infectious complica-
tions. All five patients in our cohort who died
within the first 30 days after surgery had an intra-
operative temperature of less than 36°C. These
findings suggest that there is a strong association
between end operative temperature and morbidity
and mortality. Given the modifiable nature of in-
Table 2. Association Between Hypothermia and Other Risk Factors and the Development of Any Early
Postoperative Complication
Variable
Univariable Multivariable
OR 95% CI P OR 95% CI P
Hypothermia (end of operation
temperature less than 36°C)
3.55 1.66–8.07 .002 3.35 1.45–8.28 .006
Age 75 y or older 4.50 1.93–10.79 .001 4.50 1.72–12.23 .003
BMI higher than 30 kg/m2 1.31 0.61–2.74 .48 1.67 0.66–4.24 .28
ASA score 3.15 1.48–7.16 .004 2.71 1.14–6.84 .029
Operative time longer than 4 h 1.07 0.52–2.18 .85 1.31 0.56–3.12 .54
Surgical complexity score* .65 .97
Intermediate 0.82 0.34–2.07 1.06 0.34–3.38
High 0.60 0.19–1.82 0.93 0.24–3.64
OR, odds ratio; CI, confidence interval; BMI, body mass index; ASA, American Society of Anesthesiologists.
* Surgical complexity score included three levels of complexity (low, intermediate, and high) based on previously published data.7
Table 3. Association Between Hypothermia and Individual Early Postoperative Complications
Outcome Total (n146) Hypothermic (n81) Normothermic (n65)
Univariable
OR 95% CI P
Death with 30 d 5 (3.6) 5 (6.2) 0 (0.0) 9.42 0.51–173.55 *
Infectious complication 18 (12.3) 14 (17.3) 4 (6.2) 3.19 1.08–11.71 .05
VTE event 17 (11.6) 14 (17.3) 3 (4.6) 4.32 1.33–19.37 .027
Cardiac event 7 (4.8) 6 (7.4) 1 (1.5) 5.12 0.84–97.90 .14
Bowel leak 5 (3.4) 4 (4.9) 1 (1.5) 3.32 0.48–65.87 .29
Readmission 6 (4.1) 5 (6.1) 1 (1.5) 4.21 0.66–81.73 .19
Reoperation 8 (5.5) 7 (8.6) 1 (1.5) 6.05 1.04–114.72 .10
Transfusion more than 2 units† 79 (54.1) 56 (69.1) 23 (35.4) 4.09 2.07–8.31 .001
OR, odds ratio; CI, confidence interval; VTE, venous thromboembolic.
Data are n (%) unless otherwise specified.
* Unable to estimate a P value as a result of the lack of deaths in the normothermic group.
† Blood transfusion was not considered one of the early complications included in the combined primary end point.
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traoperative normothermia, this should be the focus
of future studies to improve outcomes after radical
surgery for ovarian cancer.
Kruz and colleagues in a prospective study in
patients undergoing colorectal surgery showed that
incidence of postoperative surgical wound infection
after colon resection increases three times if the core
body temperature was reduced by 1.9°C.2 Infectious
complications after major abdominal surgery could
range from wound infection to intraperitoneal abscess
formation and sepsis. Infectious complications pro-
long hospital stay, increase costs, and often result in
delay of adjuvant chemotherapy. Hypothermia alters
immune function and may delay wound healing and
facilitate infectious processes. Studies have shown that
hypothermia impairs immunity by affecting natural
killer cell and cell-mediated antibody functions.8 Hy-
pothermia has been associated with suppressed
phagocytic activity, decreased migration of polymor-
phonuclear cells, and reduced oxidative bacterial
killing by neutrophils.9 Another indirect way through
which intraoperative hypothermia may facilitate in-
fection is related to thermoregulatory vasoconstric-
tion and subsequent tissue hypoxia.10,11
Increased metabolic demand and oxygen con-
sumption resulting from shivering12 and cold-induced
sympathoadrenal activation have been suggested to
predispose patients to myocardial ischemia.13 A pro-
spective, randomized study in patients undergoing
major cardiovascular surgery demonstrated that re-
duction of core body temperature of only 1.3°C led to
a threefold increase in the rate of perioperative mor-
bid cardiac events such as ischemia and ventricular
tachycardia.4 In our study, after adjusting for other
factors, the association between hypothermia and
cardiovascular events just exceeded statistical signifi-
cance (OR 6.06, P.056) in patients undergoing
laparotomy. Remembering that this is traditionally a
low-risk population for cardiac events, the data are
strongly suggestive of a similar effect of hypothermia
on cardiac events in patients with ovarian cancer as
reported for other surgical cases.
Hypothermia promotes abnormal platelet aggre-
gation and this may explain the increased rate of VTE
events seen in hypothermic patients in our cohort.
Consistent with this, we also observed an increased
rate of perioperative blood transfusion in hypother-
mic patients. Other studies have shown that hypother-
mia can reversibly impair platelet activation and
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Fig. 1. Overall survival in hypothermic compared with
normothermic patients.
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Fig. 2. Overall survival in hypothermic compared with
normothermic patients in A. a group with optimal cytore-
duction to less than 1 cm and B. a suboptimally cytore-
duced group.
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decrease generation of thrombin; this subsequently
leads to coagulopathy and increased intraoperative
blood loss.14,15 Hypothermia also inhibits enzymatic
reaction of the coagulation cascade, resulting in pro-
longation of prothrombin time and partial thrombo-
plastin time at hypothermic temperatures.15 Because
coagulation testing is performed at 37°C, rather than
at the patient’s actual in vivo temperature, generally
the contribution of hypothermia to objective hemor-
rhagic diathesis can be missed in the clinical setting. A
study by Schmeid and colleagues demonstrated that a
reduction of just 1.6°C in core temperature increases
blood loss by 500 mL and significantly increases
transfusion in patients undergoing hip arthroplasty.3
Our data are consistent with this observation.
We observed an increased rate of overall early
postoperative complications and perioperative mor-
tality in hypothermic patients. In fact, in this relatively
homogeneous group of patients with advanced ovar-
ian cancer undergoing moderate to high complexity
surgery, hypothermia was an independent predictor
for the development of a perioperative complication.
The cost-effectiveness of maintaining normothermia
in patients undergoing colorectal surgery and hip
arthroplasty has been shown in prospective studies.2,3
Similar results can be expected in patients with ovar-
ian cancer given the present study. Additionally,
postoperative complications may delay the start of
adjuvant chemotherapy, which can subsequently lead
to inferior oncologic outcomes. Some authors sug-
gested enhanced angiogenesis and immunosuppres-
sion as potential factors that facilitate cancer cell
seeding and metastasis in the perioperative period.16
In our patient series, we observed a significant asso-
ciation between intraoperative hypothermia and
overall survival. Whether this is 1) primarily a result
of the early mortality in five cases; 2) because of a
delay in chemotherapy in hypothermic cases; or 3) a
reflection that patients who develop hypothermia
may have poor performance status or more tumor
burden is not clear.
Several measurements to maintain core body
temperature during surgery have been advocated.
These include forced air warmers, fluid warmers, and
heated mats. Newer methods including autoregulated
heating based on the actual body temperature has
been proposed. In addition, perioperative skin warm-
ing has been shown to reduce the initial postinduction
hypothermia, intraoperative hypothermia, and post-
operative shivering, even for procedures lasting for
more than 3 hours. Furthermore, a single hour of
preoperative skin surface warming has been reported
to reduce the rate at which core hypothermia devel-
oped during the first hour of anesthesia. Irrespective
of the method, in patients undergoing total hip arthro-
plasty, even a small difference in median core intra-
operative temperature of 0.5°C resulted in signifi-
cantly less blood loss among the patients who were
warmed.17,18
Although limited by sample size, we did not find
a correlation between operative times and hypother-
mia suggesting that other factors are probably more
important. This is important given the oncologic
benefit from more complex surgical procedures to
render lowest residual disease.7 In addition to sample
size, our study was limited by using only end operat-
ing temperature to define hypothermia, as is currently
defined. We anticipate more data from the literature
regarding the most appropriate measurement of hy-
pothermia during long surgical cases. The study was
limited by the lack of direct information about coagu-
lopathy; however, blood transfusion was reported and
can be used as a surrogate for coagulation defects.
The study was also limited by the lack of full record-
ing of albumin preoperatively in all patients; this
prevented full evaluation of albumin levels in the final
multivariate model. Nevertheless, end operative tem-
perature less than 36°C remained significantly associ-
ated with early complications after adjustment for
albumin. Finally, the overall survival analysis was
limited by relatively small size precluding use of Cox
proportional hazard modeling to adjust for known
risk factors, including age, chemotherapy type, and
time from surgery to start of antibiotics. Nevertheless,
a subgroup analysis based in the subgroup of patient
who had optimal debulking.
This study addresses the role of hypothermia as a
risk factor for postoperative complications in women
undergoing cytoreductive surgery for ovarian cancer.
Our data demonstrate an association between intra-
operative hypothermia and short-term preoperative
complications and early mortality after ovarian can-
cer cytoreductive surgery. Whether hypothermia is
causal or merely a sign of endogenous patient comor-
bidities remains to be answered with prospective
studies controlling intraoperative temperature. How-
ever, this is a critically important observation because
temperature is a modifiable factor, which could result
in reduced morbidity. Our data suggest active warm-
ing methods and monitoring to maintain intraopera-
tive temperature above 36°C is reasonable and may
result in decreased morbidity and cost.
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